Ethylamine

Ethylamine

SCHEMBL23925800

CCN.Nc1nc(N)nc(N)n1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.45
LMNA P02545 3/20 0.41
HSP90AA1 P07900 1/20 0.39
CYP1A2 P05177 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HRH2 P25021 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
POLB P06746 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
DHFR P00374 1/20 0.32
HEXA P06865 1/20 0.32
HEXB P07686 1/20 0.32
CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL23581974 0.85 CASP1 (0.45) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
Alcohol SCHEMBL8078657 0.81 LMNA (0.46) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
Ethylenediamine SCHEMBL5951043 0.80 CASP1 (0.47) CASP1LMNACYP1A2SMN1; SMN2HTT
Methylamine SCHEMBL7947669 0.79 LMNA (0.47) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
Ethane SCHEMBL28243367 0.79 LMNA (0.47) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
SCHEMBL25853 0.78
SCHEMBL9583239 0.78 CASP1 (0.50) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
SCHEMBL175612 0.78 CASP1 (0.50) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2
SCHEMBL29900242 0.78
SCHEMBL9579151 0.78 CASP1 (0.50) CASP1LMNAHSP90AA1CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843342-A Fluorescence quenching immunoassay 艾德克斯实验室公司 2023-03-24 CN disclosed
EP-4136141-A2 FLUORESCENCE QUENCHING IMMUNOSSAY IDEXX Laboratories, Inc. (US) 2023-02-22 EP disclosed
US-20220082501-A1 FLUORESCENCE QUENCHING IMMUNOASSAY IDEXX LABORATORIES, INC. 2022-03-17 US disclosed
WO-2021211969-A2 FLUORESCENCE QUENCHING IMMUNOSSAY IDEXX LABORATORIES, INC. (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220082501-A1 FLUORESCENCE QUENCHING IMMUNOASSAY NQO2, FCGRT, MPO CASP1 1505/4885LMNA 1955/4885HSP90AA1 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.